BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2018
View Archived Issues
MALAT: unfairly accused of promoting metastasis?
Read More
Adaptive and innate immunity is two-way street
Read More
LY-3358966 potently inhibits intestinal phosphate absorption in animal models
Read More
New compound GDT-01 improves diabetic nephropathy in ZSF1 rats
Read More
Bispecific radioimmunoconjugates tested in novel tumor model heterogeneous for HER2 and EGFR
Read More
Peptoid-peptide hybrids targeting beta-catenin:TCF interaction show utility in PCa models
Read More
Researchers develop the first conditional Fxr2 knockout models of fragile X syndrome
Read More
Genetic variants in CD274 increase risk of Fuchs endothelial corneal dystrophy in smokers
Read More
L.E.A.F. receives pre-IND feedback from FDA for four anticancer drugs
Read More
Clotting protein could be targeted in neurodegeneration
Read More
First patient enrolled in phase II study of ANAVEX2-73 for the treatment of PDD
Read More
Mirvetuximab soravtansine combined with pembrolizumab is effective in ovarian cancer
Read More
Positive long-term data presented from pivotal phase III AMBER study of Symtuza
Read More
G2-S16 proves to be safe and effective topical vaginal microbicide against HIV in vivo
Read More
Patient enrollment ongoing in phase I study of ADG-106
Read More
Preliminary data presented from first-in-human phase I/IIa study of CAN-04
Read More
Pilot study evaluates 177Lu-DOTA-EB-TATE in patients with advanced neuroendocrine neoplasms
Read More
Scancell updates development of Modi-2 for multiple solid tumors
Read More
FDA approves Keytruda with chemotherapy for first-line metastatic squamous NSCLC
Read More
InflaRx studies IFX-1 for ANCA-associated vasculitis in phase II
Read More
IRLAB offers analysis on phase IIa results of IRL-752 in Parkinson's disease
Read More
Aura reports updated results from phase Ib/II trial of AU-011 in choroidal melanoma
Read More
Distributed Bio collaborates with H3 Biomedicine to discover novel cancer therapeutics
Read More
FDA approves Invokana to reduce risk of CV events in adults with type 2 diabetes and CV disease
Read More
Trial results suggest Alzheimer's disease modification with BAN-2401
Read More
